Akinetopsia is a rare visual condition where moving objects look jumpy or seem to disappear. People with akinetopsia may struggle to pour liquids, cross a street, or follow fast action because motion is hard to see. It can appear suddenly after brain injury, stroke, or certain medications, and it may improve if the cause is treated. Many living with akinetopsia use vision therapy strategies and safety adaptations, and doctors sometimes adjust medicines or treat the underlying brain problem. The outlook varies, but early evaluation helps with safer daily routines and support.
Overview
AkinetopsiaSymptoms
Akinetopsia causes trouble seeing motion. People may perceive moving objects as frozen or as jumpy snapshots, making tasks like pouring liquids, tracking traffic, or following gestures hard. Some notice disorientation, eyestrain, or dizziness in busy, fast-moving scenes.
Outlook and prognosis
Most people with akinetopsia find that symptoms stay stable over time. Daily workarounds—like moving more slowly, using visual cues, and structured lighting—can make movement feel safer and smoother. If akinetopsia follows a stroke or head injury, recovery sometimes tracks overall brain healing.
Causes and risk factors
Akinetopsia usually follows damage to motion-processing brain areas from stroke, traumatic brain injury, seizures, or tumors. It can also appear transiently with migraine aura or certain medications. Risk rises with cardiovascular disease, head injury, and older age.
Genetic influences
Genetics play a limited, uncertain role in akinetopsia; most cases link to brain injury, stroke, or certain medications. No single gene is clearly responsible, and inherited patterns aren’t established. Rare familial reports exist, but evidence remains sparse.
Diagnosis
The diagnosis of Akinetopsia rests on your description of motion blindness and detailed vision and neurologic exams. Specialized motion-perception tests can confirm it, and brain imaging (MRI or CT) checks for causes like stroke, injury, or seizures.
Treatment and drugs
Treatment for akinetopsia focuses on easing daily challenges and enhancing safety. Care may include tailored vision therapy, environmental adjustments (better lighting, contrasting colors), occupational therapy strategies, and addressing triggers like migraines, seizures, head injury, or medication side effects. Some benefit from tinted lenses, prism trials, or neurologic care when symptoms fluctuate.
Symptoms
Movement may seem jumpy or out of step, making everyday tasks feel unpredictable. Early symptoms of akinetopsia can be subtle—maybe cars appear to lurch forward, or water looks still until the cup overflows. Symptoms vary from person to person and can change over time. Many living with akinetopsia see clearly when things are still, but anything moving can be hard to judge.
Movement looks broken into snapshots, like a strobe effect. Fast-moving scenes can feel overwhelming because the path between positions is missing. Clinicians call this akinetopsia, which means trouble perceiving motion.
Liquids may seem frozen and then suddenly appear in a new spot. People often misjudge the level and spill or overflow. Early on, this might look like small, frequent spills at the sink.
Judging the speed of cars, bikes, or pedestrians becomes difficult. Crossing streets or merging while driving can feel risky because motion is hard to gauge. Many living with akinetopsia choose quieter routes or avoid driving at busy times.
Following a moving person, pet, or ball is challenging. Someone walking past may seem to vanish and then reappear a few steps ahead. In medical terms, this is motion blindness; in everyday life, it shows up as losing track in crowds.
How people usually first notice Akinetopsia?
People usually first notice akinetopsia when moving things seem to “jump” from place to place rather than glide—pouring tea looks like a stack of still images, or cars appear to teleport down the road. The first signs of akinetopsia often show up as trouble tracking motion in everyday tasks, like crossing the street, following a ball, or reading lips, while stationary objects remain clear. This condition is typically recognized after a brain event or injury affecting motion-processing areas, so doctors often connect new motion-vision problems with a recent stroke, head trauma, seizure activity, or certain medications rather than something present from birth.
Types of Akinetopsia
Akinetopsia affects how the brain processes motion, so daily scenes can feel jumpy or like still frames instead of smooth movement. People with akinetopsia often adapt by turning their heads more, relying on sound, or avoiding fast-moving settings such as busy streets. Clinicians often describe them in these categories:
Macroscopic akinetopsia
Motion looks like a flipbook with choppy, stepwise changes. Fast actions such as pouring water or passing cars can seem to “teleport” between positions. This type can noticeably affect walking in crowds or crossing the street.
Transient akinetopsia
Brief episodes of motion blindness come and go. Triggers can include migraine aura, certain medications, or seizures, and symptoms often resolve as the trigger fades. Not everyone will experience every type.
Mild akinetopsia
Motion feels subtly slowed or smeared rather than fully missing. People may notice trouble tracking a bouncing ball or judging the speed of cyclists, especially in low light. Early symptoms of akinetopsia can be easy to miss in calm settings.
Complete akinetopsia
Movement perception is nearly absent, so only static snapshots are seen. Everyday tasks like pouring liquids or navigating traffic become very challenging and often require workarounds. Loved ones may recognize certain types sooner than the person experiencing them.
What genetics can tell you about symptoms
Some people with certain mutations in the MT/V5 pathway genes or in the occipital cortex wiring develop akinetopsia, noticing motion as a series of frozen frames. When these genes or circuits are disrupted, the brain’s motion-processing “dimmer switch” falters, making moving objects appear jumpy or invisible.
Causes and risk factors
Akinetopsia most often happens after injury to the brain’s motion processing area, often called V5/MT. This injury can result from a stroke, a head injury, a brain tumor, or surgery near the back of the brain. There is no established inherited cause for classic akinetopsia, and most cases are acquired. Risk factors for akinetopsia mirror those for stroke and trauma, including high blood pressure, high cholesterol, diabetes, smoking, older age, and falls or car crashes. Doctors distinguish between risk factors you can change and those you can’t.
Environmental and biological risk factors
Akinetopsia, sometimes called motion blindness, can make moving scenes look jumpy or frozen, which can affect everyday things like crossing a busy street or pouring water. Understanding what raises risk helps you and your care team spot and address triggers early. Doctors often group risks into internal (biological) and external (environmental). These risks can also shape when early symptoms of akinetopsia might appear.
Blows to the head or traumatic brain injury can damage the brain’s motion-processing areas at the back of the head. When these circuits are hurt, akinetopsia can appear suddenly or after recovery begins. Risk is highest when the injury involves pathways that carry visual signals from the eyes to the brain.
Strokes affecting the rear parts of the brain can interrupt circuits that track motion. Blockages or bleeding in these regions may lead to sudden motion-perception problems, including akinetopsia. The exact effect depends on stroke size and location.
A visual form of dementia (posterior cortical atrophy) can slowly disrupt networks that read movement. As these changes spread in the visual cortex, motion blindness can emerge or progress.
Seizures that start near the brain’s motion area can temporarily disturb how movement is seen. Some people notice brief episodes of motion looking stuttered or stopped around seizure events.
Genetic risk factors
Clear, direct genetic causes for Akinetopsia have not been established. Some inherited conditions that damage the back of the brain, where motion is processed, can indirectly raise risk. Carrying a genetic change doesn’t guarantee the condition will appear. Genetics does not change early symptoms of Akinetopsia, which usually involve trouble seeing movement, but it can influence who is more susceptible when disease affects the visual motion areas.
No single gene: There is no single gene known to directly cause akinetopsia. Most cases arise after damage to motion-vision areas of the brain. Genetics may still influence how vulnerable those areas are.
Familial Alzheimer’s genes: Inherited early-onset Alzheimer’s disease (often due to changes in PSEN1, APP, or PSEN2) can lead to posterior cortical atrophy. This pattern sometimes disrupts motion processing and may include akinetopsia-like symptoms. Not everyone with these genes develops visual problems.
APOE e4 variant: A common variant called APOE e4 raises the chance of Alzheimer’s disease. In some people, the disease targets posterior brain regions that support motion vision. That distribution can increase risk of akinetopsia features.
Posterior cortical atrophy history: When posterior cortical atrophy is seen across a family, an Alzheimer’s-related biology is often shared. Families may face higher chances of dorsal visual stream difficulties, including motion perception loss. Genetic patterns can vary widely between relatives.
Hereditary small-vessel disease: A genetic small-vessel condition such as CADASIL can cause strokes in deep and posterior brain areas. If damage reaches the brain’s motion-vision networks, akinetopsia can appear. A family history of early strokes supports this inherited risk.
Lifestyle risk factors
Akinetopsia often follows brain injury or stroke affecting motion-processing areas, so certain habits can influence your risk through those pathways. This overview focuses on lifestyle risk factors for akinetopsia, emphasizing behaviors that raise head-injury or stroke risk. Changing these factors cannot guarantee prevention but can lower the chances of the brain events linked to motion-vision loss.
Skipping seatbelts or helmets and engaging in risky driving or cycling increases traumatic brain injury risk. Protecting your head reduces the chance of damage to motion-processing regions.
Repeated concussive blows in boxing, football, or hockey raise cumulative brain injury risk. Proper technique, limits on contact, and consistent helmet use reduce exposure.
Heavy drinking increases crashes, falls, and hemorrhagic or ischemic stroke risk. Cutting back lowers these pathways that could lead to motion-vision deficits.
Stimulants like cocaine and meth raise stroke risk, while sedatives increase accidents and falls. Avoiding illicit drugs reduces brain-injury routes to motion blindness.
Risk prevention
Akinetopsia is rare motion “blindness,” usually linked to brain changes from stroke, head injury, seizures, or migraine aura. You can’t fully prevent it, but you can lower risks by protecting brain and blood vessel health and acting quickly if symptoms start. Prevention is about lowering risk, not eliminating it completely. Knowing early symptoms of Akinetopsia—like trouble tracking moving cars or liquids “freezing” while pouring—can prompt urgent care that limits damage.
Keep blood pressure, cholesterol, and blood sugar in target range, and don’t smoke. This lowers stroke risk that can lead to Akinetopsia.
Wear helmets for cycling and contact sports, use seat belts, and reduce fall hazards at home. Preventing head trauma helps avoid brain injury that can cause Akinetopsia.
Track triggers, keep regular sleep and hydration, and ask about preventive medicines if attacks are frequent. Reducing aura episodes may lower the chance of motion-vision problems like Akinetopsia.
Take antiseizure medicines as prescribed and avoid known triggers like sleep loss or alcohol binges. Better control protects the brain and may reduce motion blindness episodes.
Transmission
Akinetopsia isn’t contagious—you can’t catch it from someone and it can’t be passed on through casual contact. Most people develop akinetopsia after changes in the brain, such as a stroke, head injury, or (less often) as a side effect of certain medicines or neurodegenerative conditions. There’s no evidence of regular genetic transmission of akinetopsia; when families ask how akinetopsia is inherited, doctors usually explain that it typically isn’t, and rare cases present from birth are uncommon and don’t follow a clear pattern. Because akinetopsia doesn’t spread between people, precautions focus on safety and treating the underlying cause rather than isolation.
When to test your genes
Consider genetic testing if akinetopsia appears early, clusters in your family, or comes with other neurologic signs, since rare inherited disorders can mimic or include motion-perception loss. Test sooner if results could change care—screening, medications, or rehab. Discuss timing with a neurologist or genetic counselor.
Diagnosis
People with Akinetopsia often notice that moving things seem to jump from place to place, making everyday tasks like crossing the street or pouring a drink feel tricky. You might notice small changes in daily routines, like struggling to track a moving ball or follow traffic flow. Doctors usually begin by asking detailed questions and checking vision and nerve function before ordering scans or specialized tests. The diagnosis of Akinetopsia often relies on a clear symptom history, motion-perception testing, and brain imaging to look for changes in motion-processing areas of the brain.
Your provider asks when motion problems started and what situations trigger them. Concrete examples, like difficulty watching moving traffic or following fast sports, help pinpoint the issue. Consistent patterns support the diagnosis.
Doctors assess visual acuity, eye movements, and how the eyes work together. This helps separate motion-processing problems in the brain from eye or optic nerve issues.
A slit-lamp and retinal exam look for eye diseases that could mimic motion difficulties. Visual field testing can identify blind spots that interfere with tracking movement.
Strength, coordination, balance, and sensation are checked to look for stroke or other brain disorders. Findings can guide which tests come next.
Stages of Akinetopsia
Akinetopsia does not have defined progression stages. It usually reflects a specific problem in the brain’s motion-processing areas or a medication effect, so symptoms may appear suddenly, stay stable, or improve if the cause is treated rather than advancing step by step. Early symptoms of akinetopsia can include difficulty judging moving traffic, feeling like people “jump” from place to place, or spilling liquids because the flow is hard to see. Different tests may be suggested to help confirm the diagnosis, such as detailed vision and motion-perception testing, a review of medicines, and brain imaging like MRI to look for stroke, injury, or other causes.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, especially after being told they have akinetopsia. For many living with akinetopsia, day-to-day life involves adapting to moments when moving objects seem to “jump” rather than glide—pouring coffee may look like frozen frames, and crossing a busy street can feel risky without support. The outlook is not the same for everyone, but most people find that symptoms are stable over time if the cause is not actively worsening, and they learn workarounds like relying more on sound, touch, or predictable routines.
Understanding the prognosis can guide planning and safety choices at home and outdoors. If akinetopsia comes from a temporary trigger—like a medication side effect or a short-term brain event—early symptoms of akinetopsia may ease as the trigger is treated or removed. When akinetopsia stems from permanent brain injury or a degenerative condition, symptoms tend to persist and may slowly change alongside the underlying disorder. Mortality is not directly linked to akinetopsia itself, but risk can rise indirectly if navigation or driving hazards aren’t addressed; avoiding high-speed activities, using public transit, and tailored rehab can reduce that risk.
Some people experience mild, brief episodes, while others notice ongoing difficulties that affect reading, sports, or busy environments. With ongoing care, many people maintain independence by pairing vision strategies with occupational therapy and, when needed, mobility training. Talk with your doctor about what your personal outlook might look like, including whether the cause is reversible, stable, or progressive, and which supports can help you stay safe and active.
Long-term effects
Over time, akinetopsia can make moving scenes feel fragmented or jumpy, which can reshape day-to-day tasks like walking through crowds or pouring liquids. Long-term effects vary widely, depending on the cause, the brain areas involved, and whether other vision changes are present. People sometimes mistake early symptoms of akinetopsia for eye problems, but this condition comes from how the brain processes motion. Some improve or find workarounds, while others have lasting difficulties with safety, driving, and certain jobs.
Ongoing difficulty seeing smooth movement, with objects seeming to jump from place to place. This can affect tracking cars, people, or animals. In some, akinetopsia remains stable; in others, it may change with the underlying condition.
Crowded spaces can feel chaotic and hard to judge. Stairs, escalators, and crossing streets may demand extra time. Depth and speed cues may be unreliable.
Judging speed and distance can stay unreliable over the long term. Many with akinetopsia are advised not to drive for safety. This can limit independence and job choices.
Missed motion cues raise the risk of tripping, spills, or collisions. Pouring hot liquids or stepping off curbs can be hazardous. Protective habits may develop but risk can persist.
How is it to live with Akinetopsia?
Living with akinetopsia can feel like the world jumps forward in snapshots rather than flowing smoothly, making moving crowds, pouring liquids, or crossing a street unexpectedly hard. Many find they rely on sound, touch, and position cues—listening for approaching cars, feeling water levels, or tracking objects by where they were a moment ago rather than how they move. Daily life often slows down by choice: preferring quiet, well‑lit spaces, avoiding fast visual scenes, and planning routes to reduce motion overload. For family, friends, and coworkers, patience and small adjustments—speaking before entering a room, offering a steady arm in busy places, giving extra time—can turn challenging moments into manageable ones.
Treatment and drugs
Treatment for akinetopsia focuses on easing day-to-day difficulties and addressing any underlying cause. When akinetopsia is linked to a trigger such as a stroke, seizure activity, migraine aura, head injury, or a medication side effect, treating that condition—stabilizing seizures, optimizing stroke rehab, adjusting migraine prevention, or changing medicines—may reduce visual motion problems. Vision rehabilitation can help many people with akinetopsia build practical strategies, like using high-contrast cues, improving lighting, slowing movements, and relying on sound or touch to judge motion safely (for example, crossing streets or pouring liquids). Some may benefit from occupational therapy, prism or tinted lenses trialed by low-vision specialists, and safety adaptations at home and work; your doctor may suggest a combination of lifestyle changes and drugs if there’s an associated neurologic condition. Although living with akinetopsia can feel overwhelming, supportive care can make a real difference in how you feel day to day.
Non-drug treatment
Daily life with Akinetopsia can feel tricky in motion-heavy moments—pouring coffee, stepping off a curb, or biking alongside traffic. Non-drug treatments often lay the foundation for safer routines and more confidence during these tasks. Some people first notice early symptoms of Akinetopsia when pouring liquids or crossing a busy street, and practical training can help make these moments more predictable. A team approach—often including neuro-ophthalmology, occupational therapy, and vision rehab—focuses on compensating skills rather than “fixing” motion vision.
Therapists teach step-by-step methods for daily tasks like pouring, cooking, and bathing. You practice using touch, sound, and clear visual landmarks to guide actions safely. Training is personalized to your home and routines.
Low-vision specialists coach you to rely on static cues, contrast, and lighting instead of motion. This may include using bold labels, larger markers, and positioning objects so they’re easy to locate without tracking movement. Sessions build practical habits you can use every day.
You learn a slow “pause-look-move” pattern to break moving scenes into manageable snapshots. This can help with busy sidewalks or crowded shops. Structured drills build consistency under stress.
Brighter, even lighting and decluttering reduce visual overload. High-contrast edges on steps, counters, and shower entries improve depth and placement when things are moving around you. Stable storage spots make items easier to find without tracking motion.
Your genes may have an impact on how drugs work for you
Some people with akinetopsia process medicines differently because gene variants can change how fast the body activates, breaks down, or clears a drug. This can affect dose needs and side‑effect risk, so clinicians may adjust treatment and consider pharmacogenetic testing when available.
Pharmacological treatments
There’s no medication proven to reverse akinetopsia itself. Treatments instead aim at the underlying cause—most often migraine aura, seizures, or damage from stroke or head injury. Not everyone responds to the same medication in the same way. Addressing these drivers may lessen motion-vision problems and, for some, reduce early symptoms of akinetopsia.
Propranolol, topiramate, amitriptyline, or candesartan are commonly used to reduce migraine frequency. Fewer or milder attacks may ease motion-vision disturbances linked to migraine aura.
Lamotrigine may be used off‑label to prevent frequent migraine aura when standard preventives fall short. Reducing aura can help some people with akinetopsia that flares around migraine episodes.
Triptans such as sumatriptan or rizatriptan can shorten a migraine attack when taken early. Faster relief may limit temporary worsening of akinetopsia during attacks.
Levetiracetam, lamotrigine, or valproate can help control seizures that affect visual areas. Stabilizing these events may reduce motion-vision symptoms tied to seizure activity.
Genetic influences
Most cases of Akinetopsia are acquired rather than inherited; they typically follow injury or disease affecting the brain’s motion‑processing areas at the back of the head. It’s natural to ask whether family history plays a role. Right now, there isn’t a single known gene that directly causes Akinetopsia, and clear genetic causes of Akinetopsia haven’t been established. In rare situations, inherited factors that raise the chance of stroke, certain migraines, or neurodegenerative conditions can indirectly increase the risk of damage to the brain circuits that handle motion, which may lead to similar symptoms. Because of this, sharing a detailed family history can still be useful, especially if relatives have had early strokes, unusual migraines, or disorders that affect vision and thinking. If Akinetopsia occurs alongside a known inherited condition, discussing genetic counseling may help clarify which risks are shared in the family, even though the motion blindness itself is usually not directly inherited.
Is Akinetopsia genetic?
Genetics play a limited, uncertain role in akinetopsia; most cases link to brain injury, stroke, or certain medications. No single gene is clearly responsible, and inherited patterns aren’t established. Rare familial reports exist, but evidence remains sparse.
Pharmacogenetics—how genetics influence drug effects
For Akinetopsia, there isn’t a medicine proven to restore motion perception; care usually focuses on treating the underlying cause and reducing visual strain. When medications are used—such as for migraine, seizures, anxiety, or depression—inheritance can change how quickly your body handles them and the chance of dizziness or blurred vision that could make Akinetopsia feel worse. Genetic testing can sometimes identify how your body breaks down certain antidepressants or anti‑seizure medicines, helping doctors choose a dose that balances benefit and side effects. The strongest evidence is for some antidepressants and tricyclics, and for a few anti‑seizure drugs where specific inherited markers predict a higher risk of severe skin reactions, particularly in parts of East and Southeast Asia. This can streamline treatment options for Akinetopsia by minimizing drug side effects that interfere with vision, even though the medicines are aimed at coexisting conditions rather than motion blindness itself. Response still varies with things like the brain area injured, other prescriptions, alcohol use, and sleep, so pharmacogenetic results are best used alongside your full care plan for Akinetopsia.
Interactions with other conditions
Day to day, having akinetopsia alongside another condition can make navigation and safety much harder—crossing a busy street or pouring tea may feel riskier if vision or balance is also affected. Doctors call it a “comorbidity” when two conditions occur together. Stroke, traumatic brain injury, and posterior cortical atrophy can travel with akinetopsia because they affect the same back part of the brain that processes motion; when they do, memory, attention, or spatial problems may compound the motion blindness. Rarely, brief episodes that resemble akinetopsia have been reported with migraine aura or seizures, and these can muddy the picture when trying to tell what’s driving symptoms. Early symptoms of akinetopsia can also be mistaken for issues like vertigo or anxiety—especially if a vestibular disorder or panic disorder is present—so careful evaluation matters. Eye diseases like cataracts or macular degeneration don’t cause akinetopsia, but they can reduce overall visual clarity, which may make the motion problem feel more pronounced in daily life. When multiple conditions overlap, coordinated care across neurology, eye care, and rehabilitation can help tailor strategies to reduce falls, improve reading and driving decisions, and support everyday tasks.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described moments when motion seemed to “jump” rather than flow—water appearing as frozen sheets, traffic as a series of still images. Early accounts were scattered and hard to interpret, but they hint that the experience we now call akinetopsia has long been noticed, even if it wasn’t named.
First described in the medical literature as “motion blindness” in the late 20th century, akinetopsia entered neurology through careful case reports. One landmark patient, after specific injury to motion-processing areas in the back of the brain, reported that people “popped” from one place to another and pouring tea was nearly impossible because the stream looked like glass. Initially understood only through symptoms, later imaging linked these experiences to regions near the occipital and temporal lobes that help the brain track movement.
From early theories to modern research, the story of akinetopsia moved from rare, striking cases to a clearer map of how the brain builds the sense of motion. As brain scanning improved, scientists could see which networks switch on when objects move across the visual field. Subtle, momentary forms have even been evoked in labs using visual tricks or brain stimulation, helping confirm that motion perception depends on coordinated timing across several areas, not just a single “motion center.”
In recent decades, awareness has grown that akinetopsia is not one-size-fits-all. Some people have profound difficulty perceiving any motion, while others notice brief stutters, especially with fast-moving scenes or in low light. Reports after strokes, head injuries, seizures, or certain medicines helped clinicians recognize patterns and separate akinetopsia from other visual conditions like blurred vision or problems with depth.
Advances in genetics did not reveal a single “akinetopsia gene,” but they did strengthen the broader understanding that the brain’s motion pathways are built from many interacting parts. This fits with observations that early symptoms of akinetopsia can vary and sometimes overlap with migraine aura or other transient visual phenomena, even though the underlying causes differ.
Over time, the way the condition has been understood has changed as tools improved—from bedside descriptions to high-resolution scans and controlled visual tests. Today, akinetopsia remains uncommon, but its history shows how listening closely to patients’ day-to-day challenges—crossing a street, pouring a drink, following a conversation when lips seem to jump—guided scientists toward the brain circuits that allow the world to flow smoothly rather than flicker frame by frame.